Patents by Inventor Daniel J. Tschumperlin

Daniel J. Tschumperlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043396
    Abstract: The present application provides compounds and methods for treating ocular fibrotic pathologies, including using D1 and/or D5 receptor agonists for treating proliferative vitreoretinopathy.
    Type: Application
    Filed: January 27, 2022
    Publication date: February 8, 2024
    Inventors: Andrew J. Haak, Daniel J. Tschumperlin, Sophie Bakri
  • Publication number: 20230346740
    Abstract: The present application provides methods for treating or preventing diseases and conditions associated with tissue fibrosis.
    Type: Application
    Filed: September 21, 2022
    Publication date: November 2, 2023
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Daniel J. TSCHUMPERLIN, Andrew J. HAAK
  • Publication number: 20220275002
    Abstract: The present application provides methods for treating or preventing diseases and conditions associated with tissue fibrosis.
    Type: Application
    Filed: July 29, 2020
    Publication date: September 1, 2022
    Inventors: Daniel J. Tschumperlin, Andrew J. Haak
  • Publication number: 20220267277
    Abstract: Described herein are small molecule agonists of dopamine receptor D1 that inhibit YAP/TAZ, compositions, and methods of using these compounds and compositions. The methods of using such compounds in the treatment of conditions, diseases, or disorders associated with fibrotic disease are described herein.
    Type: Application
    Filed: July 29, 2020
    Publication date: August 25, 2022
    Inventors: Brad SAVALL, Andrew J. HAAK, Daniel J. TSCHUMPERLIN
  • Publication number: 20210038561
    Abstract: The present application provides methods for treating or preventing diseases and conditions associated with tissue fibrosis.
    Type: Application
    Filed: January 31, 2019
    Publication date: February 11, 2021
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Daniel J. Tschumperlin, Andrew J. Haak